Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
76.87
+0.81 (1.06%)
Aug 10, 2026, 12:24 PM EDT - Market open
KNSA Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 175.68 | 165.6 | 183.58 | 107.95 | 122.72 | 122.47 |
Short-Term Investments | 350.25 | 248.48 | 60.05 | 98.42 | 67.89 | 59.73 |
Cash & Short-Term Investments | 525.93 | 414.07 | 243.63 | 206.37 | 190.61 | 182.2 |
Cash Growth | 70.88% | 69.96% | 18.05% | 8.27% | 4.61% | -43.68% |
Accounts Receivable | 23.49 | 15.59 | 41.72 | 21.27 | 12.66 | 3.99 |
Other Receivables | - | - | - | - | 7.66 | - |
Total Trade Receivables | 23.49 | 15.59 | 41.72 | 21.27 | 20.32 | 3.99 |
Inventory | 70.93 | 54.9 | 26.36 | 31.12 | 21.6 | 3.68 |
Other Current Assets | 48.29 | 42.61 | 20.08 | 17.54 | 10.54 | 6.59 |
Total Current Assets | 668.63 | 527.18 | 331.8 | 276.3 | 243.06 | 196.45 |
Net Property, Plant & Equipment | 10.93 | 11.75 | 11.04 | 12.67 | 7.04 | 8.38 |
Other Intangible Assets | 14.75 | 15.25 | 16.25 | 17.25 | 18.25 | 19.25 |
Other Long-Term Assets | 201.8 | 209.46 | 221.47 | 220.11 | 191.32 | 8.72 |
Total Assets | 896.11 | 763.63 | 580.55 | 526.32 | 459.67 | 232.8 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 12.4 | 2.03 | 2.04 | 8.25 | 7.9 | 1.87 |
Accrued Expenses | 134.78 | 112.04 | 80.51 | 44.67 | 30.11 | 38.03 |
Current Portion of Leases | 4.01 | 2.99 | 1.99 | 2.25 | 3.3 | 3.38 |
Unearned Revenue | - | - | - | 0.31 | - | - |
Other Current Liabilities | 20.05 | 22.13 | 16.08 | 8.19 | 5.75 | 1.54 |
Total Current Liabilities | 171.25 | 139.18 | 100.62 | 63.67 | 47.07 | 44.82 |
Long-Term Leases | 4.89 | 6.51 | 7.86 | 10.01 | 2.62 | 2.67 |
Other Long-Term Liabilities | 65.83 | 50.33 | 33.63 | 13.81 | 13.84 | 0.27 |
Total Long-Term Liabilities | 70.71 | 56.84 | 41.5 | 23.82 | 16.46 | 2.94 |
Total Liabilities | 241.96 | 196.03 | 142.12 | 87.48 | 63.52 | 47.76 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.02 | 0.02 | 0.02 | 0 | 0.02 | 0.02 |
Additional Paid-in Capital | 1,070 | 1,030 | 959.72 | 916.76 | 888.12 | 860.48 |
Accumulated Other Comprehensive Income | -1.38 | -0.03 | -0.16 | 0.01 | 0.04 | -0.07 |
Retained Earnings | -414.11 | -462.14 | -521.14 | -477.95 | -492.03 | -675.4 |
Shareholders' Equity | 654.15 | 567.61 | 438.44 | 438.84 | 396.15 | 185.04 |
Total Liabilities & Equity | 896.11 | 763.63 | 580.55 | 526.32 | 459.67 | 232.8 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 8.9 | 9.5 | 9.86 | 12.26 | 5.92 | 6.05 |
Net Cash (Debt) | 517.03 | 404.58 | 233.77 | 194.11 | 184.69 | 176.15 |
Net Cash Growth | 73.49% | 73.06% | 20.43% | 5.10% | 4.85% | -44.34% |
Net Cash Per Share | 6.32 | 5.12 | 3.27 | 2.70 | 2.62 | 2.57 |
Book Value | 654.15 | 567.61 | 438.44 | 438.84 | 396.15 | 185.04 |
Book Value Per Share | 7.99 | 7.19 | 6.14 | 6.10 | 5.63 | 2.70 |
Tangible Book Value | 639.4 | 552.36 | 422.19 | 421.59 | 377.9 | 165.79 |
Tangible Book Value Per Share | 7.81 | 6.99 | 5.91 | 5.86 | 5.37 | 2.42 |